TCGX · TCGX Acquisition Corp. · Documents
Market Cap
$113.26M
Shares
11.30M
Volume · Oct 20
1.08M
Avg daily vol (52 sessions)
124.3K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | TCGX Acquisition Corp. entered a Business Combination Agreement on October 18, 2026 with TriGemX Bio, Inc. (formerly Kallyope) to merge at a $361,000,000 pre-money equity value, with a $160,000,000 PIPE Financing, expected to close in Q1 2027. | 2026-10-19 | 2026-10-18 | |
| 10-Q | — | 2026-09-10 | 2026-06-30 | |
| 8-K | — | 2026-08-12 | 2026-08-06 | |
| 8-K | — | 2026-08-06 | 2026-08-04 | |
| S-1/A | — | 2026-07-31 | — | |
| S-1 | — | 2026-07-20 | — |
Showing 1–6 of 6 filings